Fan Lin

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

PangyPlot: multi-scale interactive visualization of pangenome variation graphs.

PangyPlot: multi-scale interactive visualization of pangenome variation graphs.

Journal: Bioinformatics (Oxford, England)
Published: April 24, 2026

Distinct regulatory elements of SLC6A14 expression contribute to modification of cystic fibrosis phenotypes.

Distinct regulatory elements of SLC6A14 expression contribute to modification of cystic fibrosis phenotypes.

Journal: Human genetics
Published: June 16, 2025

GWAS SVatalog: a visualization tool to aid fine-mapping of GWAS loci with structural variations.

GWAS SVatalog: a visualization tool to aid fine-mapping of GWAS loci with structural variations.

Journal: Heredity
Published: January 20, 2025

Ethylene glycol is metabolized to ethanol and acetate and induces expression of bacterial microcompartments in Propionibacterium freudenreichii.

Ethylene glycol is metabolized to ethanol and acetate and induces expression of bacterial microcompartments in Propionibacterium freudenreichii.

Journal: Heliyon
Published: July 19, 2023

SLCO5A1 and synaptic assembly genes contribute to impulsivity in juvenile myoclonic epilepsy.

SLCO5A1 and synaptic assembly genes contribute to impulsivity in juvenile myoclonic epilepsy.

Journal: NPJ genomic medicine
Published: March 27, 2023

Genome-wide association study of susceptibility to Pseudomonas aeruginosa infection in cystic fibrosis.

Genome-wide association study of susceptibility to Pseudomonas aeruginosa infection in cystic fibrosis.

Journal: The European respiratory journal
Published: October 10, 2022

High-quality read-based phasing of cystic fibrosis cohort informs genetic understanding of disease modification.

High-quality read-based phasing of cystic fibrosis cohort informs genetic understanding of disease modification.

Journal: HGG advances
Published: July 08, 2022

Genetic evidence supports the development of SLC26A9 targeting therapies for the treatment of lung disease.

Genetic evidence supports the development of SLC26A9 targeting therapies for the treatment of lung disease.

Journal: NPJ genomic medicine
Published: December 30, 2021

Correction to: Cystic fibrosis-related diabetes onset can be predicted using biomarkers measured at birth.

Correction to: Cystic fibrosis-related diabetes onset can be predicted using biomarkers measured at birth.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: August 14, 2021

Cystic fibrosis-related diabetes onset can be predicted using biomarkers measured at birth.

Cystic fibrosis-related diabetes onset can be predicted using biomarkers measured at birth.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: July 22, 2020

Genetic association and transcriptome integration identify contributing genes and tissues at cystic fibrosis modifier loci.

Genetic association and transcriptome integration identify contributing genes and tissues at cystic fibrosis modifier loci.

Journal: PLoS genetics
Published: August 27, 2018

SLC6A14, an amino acid transporter, modifies the primary CF defect in fluid secretion.

SLC6A14, an amino acid transporter, modifies the primary CF defect in fluid secretion.

Journal: eLife
Published: April 30, 2018
Showing 1-12 of 25

Last Updated: 09/26/2026